Literature DB >> 2846031

Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis.

T Hanada1, K Koike, T Takeya, T Nagasawa, Y Matsunaga, H Takita.   

Abstract

We report a child with hereditary spherocytosis who developed human parvovirus B19 (HPV B19)-induced transient pancytopenia. Symptoms of acute-phase illness subsided promptly after infusion of gammaglobulin containing HPV B19 antibody. The HPV B19-containing serum on admission inhibited not only erythroid colony growth but also myeloid and megakaryocyte colony growths. The inhibitory effect was abrogated by convalescent-phase serum or gammaglobulin solution containing HPV B19 antibody. These findings suggest that HPV B19-induced inhibition of haematopoiesis may be pathogenetic for transient bone marrow failure of the patient. The passive immunization may be effective in shortening the duration of acute-phase illness of HPV B19 infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846031     DOI: 10.1111/j.1365-2141.1988.tb02442.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow.

Authors:  H Baurmann; T F Schwarz; J Oertel; S Serke; M Roggendorf; D Huhn
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

2.  B19 parvovirus infection causing aplastic crisis in 3 out of 5 family members with hereditary spherocytosis.

Authors:  P T Murphy; J R O'Donnell
Journal:  Ir J Med Sci       Date:  1990-06       Impact factor: 1.568

3.  Severe bone marrow failure associated with human parvovirus B19 infection in a case with no underlying disorder.

Authors:  Chihiro Kawakami; Yukako Kono; Akiko Inoue; Kimitaka Takitani; Takayuki Ikemoto; Hiroshi Tamai
Journal:  Int J Hematol       Date:  2012-11-10       Impact factor: 2.490

Review 4.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.

Authors:  K A Weigel-Kelley; M C Yoder; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 6.  Harmful and beneficial antibodies in immune thrombocytopenic purpura.

Authors:  P A Imbach
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Transient parvovirus-associated hypoplasia of multiple peripheral blood cell lines in children with chronic hemolytic anemia.

Authors:  Brian E Cauff; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Hereditary Spherocytosis Unmasked by Human Parvovirus B19 Induced Aplastic Crisis in a Family.

Authors:  Samin Alavi; Nahid Arabi; Mohammad Kaji Yazdi; Mohammad Taghi Arzanian; Farahnaz Zohrehbandian
Journal:  Iran J Med Sci       Date:  2015-09

10.  An adult with aplastic crisis induced by human parvovirus B19 as an initial presentation of hereditary spherocytosis.

Authors:  Sook Eui Oh; Jung Han Kim; Chi Hun Choi; Kwang Hyuk Park; Joo Young Jung; Young lee Park; Min-Jeong Park
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.